Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

Detalles Bibliográficos
Autores principales: Prasopporn, Sunisa, Suppramote, Orawan, Ponvilawan, Ben, Jamyuang, Chanette, Chanthercrob, Jantappapa, Chaiboonchoe, Amphun, More-Krong, Pimkanya, Kongsri, Kamonchanok, Suntiparpluacha, Monthira, Chanwat, Rawisak, Korphaisarn, Krittiya, Okada, Seiji, Sampattavanich, Somponnat, Jirawatnotai, Siwanon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854117/
https://www.ncbi.nlm.nih.gov/pubmed/36686801
http://dx.doi.org/10.3389/fonc.2022.1124912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854117/
https://www.ncbi.nlm.nih.gov/pubmed/36686801
http://dx.doi.org/10.3389/fonc.2022.1124912

Ejemplares similares